The digital leaflet standard for EU pharma

Reform adopted Dec 2025 — start today, not when the 2028 deadline hits.

Every medicine box
can finally speak to its patient.

PharmaTag is the digital leaflet ecosystem that adds a guided, multilingual, accessible layer on top of the paper leaflet — safer for patients, smarter for pharmacists, stronger for pharma. Paper stays. Digital amplifies.

Preventing dose errors for parents. Opening the leaflet to 30 million visually impaired Europeans. Enabling surgical, lot-level recall in hours. The infrastructure the industry has been waiting for — built within the EU regulatory framework since 2018, ready to pilot today — because 2028 is too late.

Request a demo See how it works
Works on every modern smartphone 100% anonymous · GDPR by design Live in a few weeks
Content push
Live in 24h · zero reprint
Anonymous scans only
Zero patient data collected

Aligned with the EU regulatory framework

EMA · Key Principles on ePI • HMA · Joint Framework • EU Commission · Pharma Package 2023 • CMDh · Readability Standards • GDPR · Privacy by design •
Beyond compliance

Compliance is the floor.
PharmaTag is also a growth lever.

Three commercial effects turn a regulatory upgrade into a measurable P&L signal — the same mechanisms that power every premium positioning in consumer health.

// EFFECT 01

Innovation premium on shelf

A PharmaTag-enabled carton carries a silent signal to the consumer and the pharmacist: this brand went beyond the legal minimum. The same halo effect FSC, Fair Trade and traceability labels brought to consumer goods — now applied to pharma.

Premium perception without a premium price change.

// EFFECT 02

Pharmacist preference at the counter

Pharmacists recommend what they can confidently advise. PharmaTag gives them the exact same patient page — live, authorised, multilingual — that the patient takes home. Between two equivalent products, the one the pharmacist can anchor wins.

The counter, finally aligned with your brand.

// EFFECT 03

Trust, completion, repeat purchase

A patient who understands the dose, the side effects and the storage — in their own language, at 2am — finishes the treatment. Better completion, fewer complaints, stronger word-of-mouth, higher refill rate.

Better outcomes compound into brand equity.

PharmaTag does not claim a specific sales uplift percentage — early-adopter MAHs are instrumenting these effects themselves. What we guarantee is the infrastructure that makes them measurable.

The new standard in digital healthcare leaflets

One standard. Three audiences. Zero compromise.

Built for the patient, the pharmacist, and the pharma brand. Within the EU regulatory framework since 2018.

For the patient

One tap on the pack, no app, no account needed. Instantly the latest authorised leaflet, the real expiry date, in every EU language. Text-to-speech audio for the 30 million visually impaired. Pediatric dose calculator.

Safer medicines, in every home.

For the pharmacist

A trusted counter tool. Always the latest authorised content, live recall notices on scan, real-time expiry check — the same patient page you can confidently recommend.

The counter, upgraded.

For the pharma brand

Anonymous scan insights with geolocation — detect parallel exports and counterfeit products on the fly. Lot-level traceability. Live content updates without reprint. An NFC-chip embedded in the carton — always readable, unlike QR codes that can be covered, scratched or soiled. GDPR-native. EU ePI Common Standard-ready.

Innovation, ROI, compliance — together.

NFC and mobile technologies officially authorised by the EMA since 2018 (EMA/493897/2015 Rev.1) · EU Pharma Reform politically agreed on 11 December 2025 · PharmaTag operates within the EU ePI framework — as a standard, not a vendor.

Lot-level recall

One lot goes wrong?
One message. Only that lot.

Product recalls are rare — but when they happen, they're massively costly and brand-damaging. PharmaTag's NFC-chip is unique per lot. We retire the affected lot URL in minutes, patients scanning that specific lot see the recall notice instantly, and the rest of your stock keeps selling.

~2 min
URL retirement time
0
stock-wide recall
M€
saved per event
100%
brand trust preserved
The 5 pains you carry today

Your pharma business has 5 chronic pains.
None had a direct solution — until now.

01

Invisible consumer

You sell through pharmacy. You have no idea who uses your product — or how.

02

Frozen content

Leaflets printed months before the shelf. No updates without reprint.

03

Zero analytics

You fly blind on real usage, geography, engagement, content performance.

04

Pharmacist gatekeeper

Consumer relationship mediated. You can't measure your brand pull.

05

Tail-risk recall

When it hits, you recall the entire stock, not just the affected lot.

How it works

One system. Standardized.
Live in a few weeks.

PharmaTag is a five-layer infrastructure. The three patient-facing layers shown below are powered by two deeper ones — anonymous scan analytics and a regulatory bridge — that make the whole EU ePI-grade, pharma-native and durable.

See the full 5-layer infrastructure architecture and the 10-criteria test →

// STEP 01

PharmaTag NFC-chip, unique per lot

A pre-programmed PharmaTag NFC-chip embedded in your carton. Each chip carries a unique URL, keyed to lot and expiry. Compatible with all modern smartphones. Zero app to install. Zero changes to your line.

// STEP 02

Web-based patient page

The consumer taps their smartphone. A branded web page opens instantly — no app, no store, no login. Multilingual, accessible, with audio (TTS) for the ~30 million visually impaired people in Europe.

// STEP 03

The PharmaTag platform — the real tech

A centralized, GDPR-compliant, 100%-secure SaaS. It ingests anonymous scan behavior, manages multilingual content, and pushes updates to every chip live. This is the standard — not the chip itself.

Built for real patient moments

Some leaflets need to become interactive.

The paper leaflet does its regulatory job — but it cannot deliver a personalised answer when the patient needs one. PharmaTag sits alongside the paper leaflet and turns each product into a smart, guided, multilingual experience — adapted to who's holding the box.

A pediatric analgesic needs a weight-to-dose slider. A chronic medication needs always the latest warnings. A senior product needs text-to-speech (TTS) audio. A nutraceutical needs traceable health claims. PharmaTag delivers all of this — from the same carton, with no app and no patient account.

Your Brand · Your-SKU Lot L-2026-04 · Exp 03/2028 Child weight 18 kg Drag slider to child's weight 9 ml every 6h · max 4/day ▸ Side effects ▸ Warnings ▸ Composition ⚠ Expiring soon Best before 03/2028 Your Brand · Your-SKU Accessible patient page 9 ml Recommended dose every 6 hours · max 4/day Listen to the leaflet TTS · 6 languages available EN FR NL DE +2 Aa · Large text mode ✓ Latest authorised version Your Brand · Your-SKU Content updated 2h ago ▾ Dosage & how to take ▸ Side effects ▸ Contraindications ▸ Composition ▸ Storage ▸ Report an adverse event ⚠ Best before 03 / 2028 🔒 100% anonymous · GDPR

// Illustrative patient UX · weight-to-dose slider · TTS · anonymous

Pediatric products

Paracetamol syrups, nasal sprays, cough medicine. A weight-based slider calculates the exact dose. Parent is guided, error is prevented.

Chronic & long-cycle

Contraceptives, hormonal therapies, daily chronic meds. Patient always gets the latest authorised warnings and refill guidance through the same PharmaTag NFC-chip — no app, no account.

Respiratory & seasonal

Cough syrups, inhalers, throat sprays, flu remedies. Seasonal peaks → expiry risk. Real-time alerts protect patient safety.

Accessibility · senior & visually impaired

Text-to-speech audio, large-text mode, simplified language. Serves the ~30 million visually impaired Europeans who cannot read a paper leaflet today.

Nutraceuticals & phyto

Supplements, phyto-medicine, traditional remedies. Traceable health claims, science evidence accessible to consumers, trust signals built-in.

Multi-country portfolios

Multilingual brands distributed across EU. Language auto-detected on scan. Multi-SmPC synchronization. One carton, every market.

5 pains solved

One system, five levers.
One measurable impact each.

Consumer understanding

invisible → anonymous signals

Aggregate scan behavior by SKU, lot, geo — never by person.

Anonymous · aggregated

Live content updates

months → < 24h

Push server-side. Zero reprints.

Operational efficiency

Real-time analytics

0 data → full dashboard

Scan volume, geo, section depth, rotation signals.

Data-driven decisions

Pharmacist amplification

counter-side value tool

Your brand, ready to advise the patient.

Stronger sell-out

Compliance + recall

ePI-ready + lot-level

Future-proof + surgical recall.

Risk mitigation
Real-time scan analytics

For the first time, you see
your product in the wild.

Every PharmaTag NFC-chip tap feeds a dashboard you control. 100% anonymous scan behavior — we never collect first-party patient data. Aggregated by SKU, lot, language, country — never by person.

dashboard.pharmatag.eu · your-brand · your-sku
Live 30 days view

Scans · 30d

12,412

+8.4%vs prev.

Anonymous sessions

9,847

+12.1%

Repeat rate

23.4%

+2.8pp

Expiry alerts

472

stock action

Scan volume · 30 days

Peaks at 18h–21h · weekend +42%

30d7d24h

Sections read

80%Dosage
Dosage80%
Warnings63%
Side effects41%

Hourly activity · last 7 days

low
high
MonTueWedThuFriSatSun

Top regions

Brussels32%
Antwerp21%
Liège14%
Ghent11%
Namur8%
100% anonymous scan behavior · never personal data · GDPR by design
Export CSVAPIPDF report

Illustrative dashboard with sample data. Your real dashboard is personalized to your SKUs, languages, and markets.

Regulatory & trust

Built inside the EU
regulatory framework.

PharmaTag is structurally aligned with the EU Electronic Product Information framework. We operate inside the boundaries the regulators themselves are defining — so your adoption is safe, durable, and future-proof.

Read the complete 2026 EU ePI regulatory briefing, with verbatim quotes from EMA and HMA concept papers →

EU · 2020

EMA / HMA / EC ePI framework

Fully aligned with the joint EMA / HMA / European Commission Key Principles on electronic Product Information (published 2020, actively maintained). Our architecture follows the structure the EU regulators themselves designated as the direction of travel.

EU · 2023

EU Pharma Package revision

The Commission's proposed legislative overhaul (COM(2023) 192/193) anticipates digital leaflet frameworks explicitly. Brands adopting PharmaTag today anticipate the regulatory direction the EU is setting for the next decade.

CMDh · Standards

Readability & accessibility

Mobile-first layout, zoomable text, text-to-speech audio, multilingual support, clear hierarchy. Serves the ~30 million visually impaired Europeans who cannot comfortably read a paper leaflet today. Patient safety by design.

GDPR · by design

Zero first-party patient data · ever

PharmaTag never collects first-party patient data. Only anonymous scan behavior — fully aggregated at SKU, lot, country and language level. 100% secure, centralized, GDPR by design. Patients stay private. Brands still see everything they need.

Resources & insights

The EU pharma
briefing room.

In-depth, sourced briefings for Regulatory Affairs, QA, Medical Affairs and Chief Digital Officers preparing their organisation for EU ePI. Every claim referenced to EMA, HMA, CMDh or the Commission. Five articles — read in order for maximum conviction, or pick the one matching your next meeting.

Regulatory guide · featured 12 min read

EU ePI Regulation 2026 — The Complete Compliance Guide

Everything pharma MAHs need to know about Electronic Product Information in 2026: the 2020 EMA / HMA / EC Key Principles, the 2023 Pharma Package revision (COM(2023) 192 and 193), the proposed Article 58 amendment, and why NFC is explicitly named in the Commission's concept paper.

EMA HMA COM(2023) 192 / 193 CMDh GDPR
Read the full guide
Policy brief · just published 10 min read

Paper + NFC: the coexistence standard for EU ePI

Why the digital-divide argument makes the case for NFC digital leaflets — not against them. Consumer (BEUC 79%), pharmacist (PGEU), carton-maker (ECMA/MLPS), Parliament (MEP Tilly Metz) and the post-trilogue Directive all converge on one architectural principle: complementarity. Here is what that means for MAH procurement.

BEUC Eurostat PGEU Complementarity Post-trilogue 2025
Read the policy brief
Manifesto · 01 7 min

The end of the digital leaflet vendor race — why pharma needs a standard, not a supplier

An opinionated brief on why the vendor race is a trap, why the EU regulation is forcing infrastructure-grade adoption, and what to do instead.

Read the manifesto
Category · 02 9 min

What is a digital leaflet infrastructure? (And why pharma needs one, not a patch.)

The 5 architectural layers every pharma lab needs: hardware, patient experience, content management, analytics, regulatory bridge. Plus a 10-criteria test.

See the 5 layers
RFP arsenal · 03 6 min

8 questions your digital leaflet vendor can't answer — and why the standard can

Copy-paste-ready RFP block for Reg Affairs, QA and CDO directors. Filters out 95% of current market offerings.

Get the RFP block
About

Belgium-based.
European-focused.
Built for the standard.

PharmaTag was founded by Belgian pharma and packaging operators who lived the frustration of frozen paper leaflets and blind recalls from the inside.

We built PharmaTag to become the EU-wide digital leaflet standard — not just another tool, but the infrastructure your category will run on. We work from Brussels. We pilot with pharma and Consumer Health brands. We scale EU-wide — always in alignment with EMA, HMA, and national regulators.

Paul De Backer, Managing Director PharmaTag

Paul De Backer

Managing Director

info@pharmatag.eu +32 477 92 18 54

"We build infrastructure, not apps. PharmaTag is to pharma what FSC is to sustainable wood — a standard that becomes the default way the industry operates."

— PharmaTag

Read the standard-not-a-vendor manifesto →
Contact

Let's talk about your
product experience.

Request a 30-minute demo call. We walk you through the patient experience, the SaaS dashboard, and scope what a pilot would look like for your product.

Request a demo

Send us an email — we come back with a calendar link within 24 hours.

info@pharmatag.eu +32 477 92 18 54
Paul De Backer, Managing Director PharmaTag

Paul De Backer

Managing Director · PharmaTag

+32 477 92 18 54

What's in a 30-min demo

  • Live scan of a PharmaTag NFC-chip on your phone
  • Walkthrough of the SaaS Manager and analytics dashboard
  • Discussion on what a pilot would look like for your SKUs
  • Q&A with the PharmaTag team — regulatory, technical, integration
  • Mutual NDA template sent post-call if you want to go deeper

Before your demo

Sharpen your evaluation with the 8 RFP questions that separate a standard from a patch — copy-paste-ready for your next procurement.

Confidentiality first

Every deeper conversation starts under mutual NDA. Your IP and commercial information are protected from minute zero.